ACI 6th Annual Summit on Biosimilars
June 1, 2015

Axinn Partner Chad Landmon participated in the panel discussion, "The Road Ahead: Minimizing the Uncertainty Surrounding FDA Standards for Interchangeability and Biosimilarity," at the American Conference Institute's 6th Annual Summit on Biosimilars on June 1, 2015 in New York.  

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.